Rhopressa

— THERAPEUTIC CATEGORIES —
  • Glaucoma

Rhopressa Generic Name & Formulations

General Description

Netarsudil 0.02%; oph soln; contains benzalkonium chloride.

Pharmacological Class

Rho kinase inhibitor.

How Supplied

Soln—2.5mL

Generic Availability

NO

Rhopressa Indications

Indications

Open-angle glaucoma. Ocular hypertension.

Rhopressa Dosage and Administration

Adult

≥18yrs: Instill 1 drop into the affected eye(s) once daily in the PM.

Children

<18yrs: not established.

Rhopressa Contraindications

Not Applicable

Rhopressa Boxed Warnings

Not Applicable

Rhopressa Warnings/Precautions

Warnings/Precautions

Concurrent corneal disease or disruption of the ocular epithelial surface. Contact lenses (remove; may reinsert lenses 15mins after administration). Pregnancy. Nursing mothers.

Rhopressa Pharmacokinetics

See Literature

Rhopressa Interactions

Interactions

Allow at least 5mins between application of other topical oph agents.

Rhopressa Adverse Reactions

Adverse Reactions

Conjunctival hyperemia, corneal verticillata, instillation site pain/erythema, conjunctival hemorrhage, corneal staining, blurred vision, increased lacrimation, erythema of eyelid, reduced visual acuity; bacterial keratitis.

Rhopressa Clinical Trials

See Literature

Rhopressa Note

Not Applicable

Rhopressa Patient Counseling

See Literature